Gamma-secretase inhibition (GSI), which has been used to block oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia (29, 35), did not alter the modest upregulation of cell-surface MHC class I with short-term TAS1440 treatment (Figure 4K). Here, NOTCH1 is linked to T-cell acute lymphoblastic leukemia.